Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis

被引:99
作者
Haider, Lukas [1 ,2 ]
机构
[1] Med Univ Vienna, Ctr Brain Res, Dept Neuroimmunol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, A-1090 Vienna, Austria
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NITRIC-OXIDE SYNTHASE; MITOCHONDRIAL-DNA MUTATIONS; ENDOTHELIN-1; PLASMA-LEVELS; APPEARING WHITE-MATTER; CENTRAL-NERVOUS-SYSTEM; DEEP GREY-MATTER; DOUBLE-BLIND; CIGARETTE-SMOKING; INCREASED EXPRESSION;
D O I
10.1155/2015/725370
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Multiple sclerosis is a chronic inflammatory demyelinating disease of the central nervous system. Different trigger pathologies have been suggested by the primary cytodegenerative "inside-out" and primary inflammation-driven "outside-in" hypotheses. Recent data indicate that mitochondrial injury and subsequent energy failure are key factors in the induction of demyelination and neurodegeneration. The brain weighs only a few percent of the body mass but accounts for approximately 20% of the total basal oxygen consumption of mitochondria. Oxidative stress induces mitochondrial injury in patients with multiple sclerosis and energy failure in the central nervous system of susceptible individuals. The interconnected mechanisms responsible for free radical production in patients with multiple sclerosis are as follows: (i) inflammation-induced production of free radicals by activated immune cells, (ii) liberation of iron from the myelin sheets during demyelination, and (iii) mitochondrial injury and thus energy failure-related free radical production. In the present review, the different sources of oxidative stress and their relationships to patients with multiple sclerosis considering tissue injury mechanisms and clinical aspects have been discussed.
引用
收藏
页数:10
相关论文
共 154 条
[1]   Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases [J].
Aboul-Enein, F ;
Rauschka, H ;
Kornek, B ;
Stadelmann, C ;
Stefferl, A ;
Brück, W ;
Lucchinetti, C ;
Schmidbauer, M ;
Jellinger, K ;
Lassmann, H .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (01) :25-33
[2]   NADPH oxidase [J].
Babior, BM .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (01) :42-47
[3]   The neutrophil NADPH oxidase [J].
Babior, BM ;
Lambeth, JD ;
Nauseef, W .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 397 (02) :342-344
[4]   Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla [J].
Bagnato, Francesca ;
Hametner, Simon ;
Yao, Bing ;
van Gelderen, Peter ;
Merkle, Hellmut ;
Cantor, Fredric K. ;
Lassmann, Hans ;
Duyn, Jeff H. .
BRAIN, 2011, 134 :3599-3612
[5]  
Bal-Price A, 2001, J NEUROSCI, V21, P6480
[6]   Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion [J].
Barnett, MH ;
Prineas, JW .
ANNALS OF NEUROLOGY, 2004, 55 (04) :458-468
[7]   Hyperbaric Oxygen Therapy for Multiple Sclerosis [J].
Bennett, Michael ;
Heard, Robert .
CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (02) :115-124
[9]   Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase [J].
Brown, G. C. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :1119-1121
[10]   DISTRIBUTION OF PLAQUES IN CEREBRUM IN MULTIPLE SCLEROSIS [J].
BROWNELL, B ;
HUGHES, JT .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1962, 25 (04) :315-+